Imovax Polio

Imovax Polio Dosage/Direction for Use

vaccine, poliomyelitis

Manufacturer:

Sanofi Pasteur

Distributor:

Zuellig
Full Prescribing Info
Dosage/Direction for Use
Dosage regimen compliant with French recommendations: Pediatric population: One dose at the age of 2 months and one dose at the age of 4 months, followed by a booster dose at the age of 11 months.
Non vaccinated adults: Two successive doses of 0.5 ml at an interval of two months, followed by a booster dose 8 to 12 months after the first injection.
Please refer to official recommendations for any further boosters.
Other dosage regimens: This vaccine must be used according to effective official recommendations.
In countries where a live Oral Poliomyelitis vaccine (trivalent, bivalent or monovalent OPV) is used in the routine immunisation programme, IMOVAX POLIO may be used in association (co-administration) or in sequential use with OPV), in accordance with official recommendations.
Missed Dose: If patient forgot to take a dose of vaccine, the doctor will decide when to administer this dose.
Method of administration: This vaccine will be administered by a healthcare professional, preferably into a muscle (intramuscular route) or under the skin (subcutaneous route).
This vaccine must never be administered into a blood vessel.
Injection into a muscle will be preferably performed in the upper side of the thigh in young children and in the upper of the arm in children, adolescents and adults.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in